No Data
No Data
TD Cowen Maintains Exact Sciences(EXAS.US) With Buy Rating, Cuts Target Price to $75
Express News | Exact Sciences Corp : TD Cowen Cuts Target Price to $75 From $86
Bernstein Reaffirms Their Buy Rating on Exact Sciences (EXAS)
New tariffs coming? The Trump administration has launched an investigation into imported Pharmaceuticals and Semiconductors.
The Trump administration has initiated a National Security investigation into imported Pharmaceuticals and Semiconductors under Section 232 of the Trade Expansion Act, which may further escalate the comprehensive trade war initiated by Trump.
Trump has initiated a 232 investigation and plans to impose tariffs on Semiconductors and Pharmaceuticals.
The Trump administration officially launched investigations into the National Security of Semiconductors and Pharmaceuticals, paving the way for further tariff increases.
Here's Why Exact Sciences (NASDAQ:EXAS) Can Afford Some Debt